Prime Medicine, Inc. - Common Stock, $0.00001 par value (PRME)

152 filings reported holding PRME - Prime Medicine, Inc. - Common Stock, $0.00001 par value as of Q1 2025.
Prime Medicine, Inc. - Common Stock, $0.00001 par value (PRME) has 121 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 60.3M shares of 179M outstanding shares and own 33.76% of the company stock.
Largest 10 shareholders include Alphabet Inc. (15.1M shares), BlackRock, Inc. (4.31M shares), T. Rowe Price Investment Management, Inc. (4.14M shares), FMR LLC (3.75M shares), VANGUARD GROUP INC (3.64M shares), ARK Investment Management LLC (3.1M shares), Sumitomo Mitsui Trust Group, Inc. (2.93M shares), Nikko Asset Management Americas, Inc. (2.93M shares), Redmile Group, LLC (2.07M shares), and MWG Management Ltd. (1.79M shares).
This table shows the top 121 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.